Inhibition of platelet aggregation by rat globin

Thrombosis Research

Volumn 107, Issue 5, 2002, Pages 201-207

  Singh, Mahendra P ^a   Sinha, Sudhir ^a   Raghavan, Santhanam A V ^a   Dikshit, Madhu ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

CD62; Intracellular calcium; Platelet aggregation; Protein factor of neutrophil supernatant; Rat globin

Indexed keywords

ACETONE; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; GLOBIN; PADGEM PROTEIN; ANTITHROMBOCYTIC AGENT; CALCIUM;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; ELUTION; FAST PROTEIN LIQUID CHROMATOGRAPHY; GEL FILTRATION CHROMATOGRAPHY; HUMAN; MALE; NONHUMAN; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; RAT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; ISOLATION AND PURIFICATION; MACACA; METABOLISM; MOLECULAR GENETICS; NEUTROPHIL; SPRAGUE DAWLEY RAT;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLOBINS; MACACA MULATTA; MALE; MOLECULAR SEQUENCE DATA; NEUTROPHILS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036761811     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00346-8     Document Type: Article

References (38)

1. Cerletti C., Evangelista V., de Gaetano G. Polymorphonuclear leukocyte-dependent modulation of platelet function. Relevance to the pathogenesis of thrombosis. Pharmacol. Res. 6:1992;261-268.
2. Dikshit M., Kumari R. Modulation of platelet aggregation response by factors released from polymorphonuclear leukocytes. Hematology. 2:1997;39-53.
3. Eldor A., Krausz Y., Altan H., Snyder D., Goldfarb A., Hy-Am E.et al. Platelet survival in patients with beta thalassemia. Am. J. Hematol. 32:1998;94-99.
4. Renesto P., Chignard M. Neutrophil-mediated platelet activation: a key role for serine proteinases. Gen. Pharmacol. 26:1995;905-910.
5. Canoso R.T., Rodview R., Scoon K., Levine P.H. Hydrogen peroxide and platelet function. Blood. 43:1974;645-656.
6. Handin L.I., Karabin R., Boxer G.J. Enhancement of platelet function by superoxide anions. J. Clin. Invest. 59:1977;959-965.
7. Oudinet J.P., Sraer J., Bens M., Armadillo R. Influence of polymorphonuclear leukocytes on the metabolism of arachidonic acid in human platelets. Thromb. Haemost. 60:1988;59-62.
8. Dikshit M., Kumari R., Srimal R.C. Pulmonary thromboembolism induced alterations in nitric oxide from rat circulating neutrophils. J. Pharmacol. Exp. Ther. 265:1993;1269-1273.
9. Rimele T.J., Strum R.J., Adams L.M., Henry D.E., Haeslip R.J., Weichman B.M.et al. Interaction of neutrophils with vascular smooth muscle. Identification of a neutrophil derived relaxing factor. J. Pharmacol. Exp. Ther. 245:1988;102-111.
10. Salvemini D., De Nucci G., Gryglewski R.J., Vane J.R. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide like factor. Proc. Natl. Acad. Sci. U. S. A. 86:1989;6328-6332.
11. Liu J.J., Xie B., Smith I.L., Johnston C.I., Buxton B.F. A stable leukocyte derived factor inhibits platelet aggregation. Biochem. Biophys. Res. Commun. 201:1994;878-882.
12. Kumari R., Singh M.P., Seth P., Dikshit M. Inhibition of platelet aggregation by a protein factor present in rat neutrophil supernatant. Thromb. Res. 91:1998;75-82.
13. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin-phenol reagent. J. Biol. Chem. 193:1951;265-275.
14. Triadou P., Fonty E., Ambrosio A.S., Cottat M.C., Girot R., Cornu P. Platelet function in sickle cell disease during steady state. Nouv. Rev. Fr. Hematol. 32:1990;137-142.
15. +2 inducers with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;1158-1160.
16. Huang T.F., Shue J.R., Teng C.M. A potent antiplatelet peptide triflavin from Trimeresueus flavoridis snake venom. Biochem. J. 277:1991;351-357.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
18. Matsudaira P. Sequence from picomole quantities of proteins electroblotted on to the polyvinyl diphenylfluoride membranes. J. Biol. Chem. 262:1987;10035-10038.
19. Johnson-Tidey R.R., Mc Gregor J.L., Taylor P.R. Increase in the adhesion molecule P-selectin in endothelium overlaying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am. J. Pathol. 144:1994;952-958.
20. Kabakus N., Yilmaz B., Caliskan U. Investigation of platelet aggregation by impedance and optic methods in children with iron deficiency anaemia. Haematologia. 30:2000;107-115.
21. Antonucci R., Walker R., Herion J., Orringer E. Enhancement of sickle cell erythrocyte adherence to endothelium by autologous platelets. Am. J. Hematol. 34:1990;44-48.
22. Greenbaum B.H., Kim H.C. Recurrent strokes in two siblings with sickle cell disease and von Willebrand's disease: implications of the role of platelets. Pediatr. Hematol. Oncol. 5:1988;239-244.
23. Adamides S., Konsantopoulas K., Toumbis M., Douratsos D., Travlou A., Kasfiki A. A study of beta thromboglobulin and platelet factor-4 plasma levels in steady state sickle cells patients. Blut. 61:1990;245-247.
24. Berney S.I., Ridler C.D., Stephens A.D., Thomas A.E., Kovaer I.V. Enhanced platelet reactivity and hyper coagulability in the steady state of sickle cell anemia. Am. J. Hematol. 40:1992;290-294.
25. Browne P.V., Moscher D.F., Steinberg M.H., Hebbel R.P. Disturbance of plasma and platelet thrombospondin levels in sickle cell disease. Am. J. Hematol. 51:1996;296-301.
26. 2 agonist U46619. Arterioscler. Thromb. 13:1993;421-426.
27. Hanna W., McCarrol D., Lin D., Chua W., Mc Donald T.P., Chen J.et al. A study of Caucasian family with variant von Willebrand's disease in association with vascular telangiectasia and haemoglobinopathy. Thromb. Haemost. 51:1984;275-278.
28. Longenecker G.L., Beyers B.J., Mancad V.N. Platelet regulatory prostanoids and platelet release products in sickle cell disease. Am. J. Hematol. 40:1992;12-19.
29. Mills K.J., Ibe B.O., Natta C.L., Raj J.U., Siegel R.S., Lessin L.S. Elevated urinary levels of thromboxane and prostacyclin metabolites in sickle cell disease reflects activated platelets in the circulation. Br. J. Haematol. 87:1994;580-585.
30. Oh S.O., Ibe B.O., Johnson C., Mills K.J., Raj J.U. Platelet activating factor in plasma of patients with sickle cell disease in steady state. J. Lab. Clin. Med. 130:1997;191-196.
31. Wun T., Paglie T., Tablin F., Welborn J., Nelson K., Cheung A. Platelet activation and platelet erythrocyte aggregate in patients with sickle cell disease. J. Lab. Clin. Med. 129:1997;507-516.
32. Leichtman D.A., Brewer G.J. A plasma inhibitor of ristocetin-induced platelet aggregation in patients with sickle hemoglobinopathies. Am. J. Hematol. 2:1977;251-258.
33. Isarangkura P., Pintadit P., Hathirat P., Sasanakul W. Platelet function tests in thalassemic children. Birth Defects Orig. Artic. Ser. 23:1987;395-401.
34. Demopoulos C.A., Andrikopoulos N.K., Stethopoulou-Sparou R. Abnormal platelet response to PAF and ADP in beta thalessemia. Int. J. Biochem. 20(6):1998;599-604.
35. Opatkiattikul N., Furahara Y., Fucharoen S., Talalak P. Increase in spontaneous platelet aggregation in beta thalassemia/hemoglobin E disease: a consequence of spectomy. Southeast Asian J. Trop. Med. Public Health. 23(Suppl. 2):1920;36-41.
36. Stuart M.J. Platelet dysfunction in homozygous beta thalassemia. Pediatr. Res. 13:1979;1345-1349fs.
37. Zatta A., Pandolfo L., Caparrotta L., Prosdocimi M., Dejana E., del Maschio A. Platelet aggregation induced by the endoperoxide analogue U46619 is inhibited by polymorphonuclear leukocyte ADPase activity. Arterioscler. Thromb. 3:1993;696-701.
38. Padoin E., Alexandre A., Cavallini L., de Laureto P., Rao H.R.G., Doni M.G. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor. Arch. Biochem. Biophys. 333:1996;407-413.